About Hoffmann - La Roche Inc
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Clinical Trials at Hoffmann - La Roche Inc
During the past decade, Hoffmann - La Roche Inc conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies
Completed
600
Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.
Completed
A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT)
Completed
The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children
Completed
28
A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients
Completed
4,000
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hoffmann - La Roche Inc
According to Clinical.Site data, the most researched conditions in "Hoffmann - La Roche Inc" are
"HIV Infections" (5 trials). Many other conditions were trialed in "Hoffmann - La Roche Inc" in a lesser frequency.
Clinical Trials Intervention Types at Hoffmann - La Roche Inc
Most popular intervention types in "Hoffmann - La Roche Inc" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Zalcitabine" (3 trials), "Saquinavir" (2 trials) and "Nelfinavir mesylate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hoffmann - La Roche Inc
The vast majority of trials in "Hoffmann - La Roche Inc" are
5 trials for "All" genders.
Clinical Trials Status at Hoffmann - La Roche Inc
Currently, there are NaN active trials in "Hoffmann - La Roche Inc".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Hoffmann - La Roche Inc,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hoffmann - La Roche Inc, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".